News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
409,856 Results
Type
Article (20168)
Company Profile (300)
Press Release (389388)
Multimedia
Podcasts (62)
Webinars (11)
Section
Business (128419)
Career Advice (394)
Deals (21871)
Drug Delivery (63)
Drug Development (59283)
Employer Resources (68)
FDA (8340)
Job Trends (8999)
News (215132)
Policy (16049)
Tag
Academia (1626)
Accelerated approval (4)
Adcomms (13)
Allergies (65)
Alliances (40741)
ALS (81)
Alzheimer's disease (1099)
Antibody-drug conjugate (ADC) (129)
Approvals (8371)
Artificial intelligence (201)
Autoimmune disease (22)
Automation (12)
Bankruptcy (200)
Best Places to Work (7714)
BIOSECURE Act (12)
Biosimilars (76)
Biotechnology (245)
Bladder cancer (68)
Brain cancer (25)
Breast cancer (216)
Cancer (1853)
Cardiovascular disease (138)
Career advice (333)
Career pathing (13)
CAR-T (137)
Cell therapy (401)
Cervical cancer (13)
Clinical research (48212)
Collaboration (824)
Compensation (297)
Complete response letters (16)
COVID-19 (1607)
CRISPR (43)
C-suite (214)
Cystic fibrosis (87)
Data (1771)
Decentralized trials (2)
Denatured (22)
Depression (38)
Diabetes (179)
Diagnostics (3354)
Digital health (11)
Diversity (9)
Diversity, equity & inclusion (18)
Drug discovery (109)
Drug pricing (43)
Drug shortages (8)
Duchenne muscular dystrophy (92)
Earnings (43334)
Editorial (23)
Employer branding (6)
Employer resources (64)
Events (67616)
Executive appointments (620)
FDA (9267)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (703)
Gene editing (106)
Generative AI (17)
Gene therapy (302)
GLP-1 (482)
Government (2192)
Grass and pollen (2)
Guidances (38)
Healthcare (11868)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (119)
Indications (24)
Infectious disease (1709)
Inflammatory bowel disease (123)
Inflation Reduction Act (9)
Influenza (41)
Intellectual property (83)
Interviews (39)
IPO (10610)
IRA (17)
Job creations (1604)
Job search strategy (296)
Kidney cancer (8)
Labor market (12)
Layoffs (296)
Leadership (7)
Legal (2677)
Liver cancer (49)
Lung cancer (253)
Lymphoma (122)
Machine learning (3)
Management (25)
Manufacturing (243)
MASH (63)
Medical device (6526)
Medtech (6529)
Mergers & acquisitions (11723)
Metabolic disorders (495)
Multiple sclerosis (66)
NASH (17)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1580)
NextGen: Class of 2025 (4292)
Non-profit (2847)
Now hiring (22)
Obesity (247)
Opinion (147)
Ovarian cancer (69)
Pain (62)
Pancreatic cancer (71)
Parkinson's disease (138)
Partnered (24)
Patents (159)
Patient recruitment (92)
Peanut (39)
People (37987)
Pharmaceutical (54)
Pharmacy benefit managers (5)
Phase I (16375)
Phase II (22110)
Phase III (14902)
Pipeline (1052)
Policy (74)
Postmarket research (1082)
Preclinical (6793)
Press Release (49)
Prostate cancer (90)
Psychedelics (36)
Radiopharmaceuticals (236)
Rare diseases (332)
Real estate (3169)
Recruiting (27)
Regulatory (12647)
Reports (17)
Research institute (1575)
Resumes & cover letters (59)
Rett syndrome (5)
RNA editing (5)
RSV (19)
Schizophrenia (66)
Series A (130)
Series B (78)
Service/supplier (3)
Sickle cell disease (47)
Special edition (11)
Spinal muscular atrophy (129)
Sponsored (20)
Startups (3004)
State (1)
Stomach cancer (7)
Supply chain (51)
Tariffs (23)
The Weekly (39)
Vaccines (404)
Venture capitalists (36)
Weight loss (149)
Women's health (25)
Worklife (3)
Date
Today (38)
Last 7 days (652)
Last 30 days (1927)
Last 365 days (25264)
2025 (8283)
2024 (26937)
2023 (30081)
2022 (36715)
2021 (39448)
2020 (36516)
2019 (30197)
2018 (22143)
2017 (21047)
2016 (18870)
2015 (22597)
2014 (16130)
2013 (12058)
2012 (12426)
2011 (12842)
2010 (11764)
Location
Africa (341)
Alabama (52)
Alaska (7)
Arizona (109)
Arkansas (10)
Asia (26137)
Australia (4474)
California (4776)
Canada (1523)
China (453)
Colorado (200)
Connecticut (213)
Delaware (124)
Europe (58454)
Florida (638)
Georgia (148)
Idaho (40)
Illinois (380)
India (19)
Indiana (166)
Iowa (8)
Japan (135)
Kansas (85)
Kentucky (12)
Louisiana (9)
Maine (53)
Maryland (670)
Massachusetts (3680)
Michigan (127)
Minnesota (237)
Mississippi (2)
Missouri (54)
Montana (26)
Nebraska (8)
Nevada (42)
New Hampshire (32)
New Jersey (1277)
New Mexico (24)
New York (1348)
North Carolina (754)
North Dakota (8)
Northern California (2079)
Ohio (151)
Oklahoma (11)
Oregon (27)
Pennsylvania (993)
Puerto Rico (7)
Rhode Island (24)
South America (475)
South Carolina (14)
South Dakota (1)
Southern California (1831)
Tennessee (77)
Texas (609)
United States (17341)
Utah (107)
Virginia (112)
Washington D.C. (37)
Washington State (412)
West Virginia (3)
Wisconsin (31)
409,856 Results for "partner therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Silence Quiets Phase III Pace for Lipoprotein Drug, Seeks Partner
The search for a partner for zerlasiran is ongoing, according to Silence. In the meantime, the biotech will focus its resources on divesiran, which it is testing for polycythemia vera and other hematologic indications.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.
April 21, 2025
·
3 min read
Press Releases
AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference
March 3, 2025
·
1 min read
Press Releases
Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer
April 10, 2025
·
2 min read
Press Releases
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference
March 3, 2025
·
1 min read
Press Releases
Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference
March 4, 2025
·
2 min read
Press Releases
Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference
March 10, 2025
·
1 min read
Press Releases
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
March 5, 2025
·
1 min read
1 of 40,986
Next
